APP and Cognitive impairment: Wan L et al. found that CPPs attenuate Aβ pathology in APP/PS1 mice and that downregulation of BACE1 may be a potential mechanism which could serve as a therapeutic target to attenuate cognitive deficits in AD pathology (Wan et al., 2020).